Nuclear IKKα mediates microRNA-7/-103/107/21 inductions to downregulate maspin expression in response to HBx overexpression

Maspin is a tumor suppressor that stimulates apoptosis and inhibits metastasis in various cancer types, including hepatocellular carcinoma (HCC). Our previous study has demonstrated that HBx induced microRNA-7, 103, 107, and 21 expressions to suppress maspin expression, leading to metastasis, chemoresistance, and poor prognosis in HCC patients. However, it remains unclear how HBx elicits these microRNA expressions. HBx has been known to induce aberrant activation and nuclear translocation of inhibitor-κB kinase-α (IKKα) to promote HCC progression. In this study, our data further revealed that nuclear IKKα expression was inversely correlated with maspin expression in HBV-associated patients. Nuclear IKKα but not IKKβ reduced maspin protein and mRNA expression, and inhibition of IKKα reverses HBx-mediated maspin downregulation and chemoresistance. In response to HBx overexpression, nuclear IKKα was further demonstrated to induce the gene expressions of microRNA-7, −103, −107, and −21 by directly targeting their promoters, thereby leading to maspin downregulation. These findings indicated nuclear IKKα as a critical regulator for HBx-mediated microRNA induction and maspin suppression, and suggest IKKα as a promising target to improve the therapeutic outcome of HCC patients.

[1]  Yun-Ju Chen,et al.  HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3 , 2015, Oncotarget.

[2]  Yun-Ju Chen,et al.  Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6 , 2015, Oncotarget.

[3]  S. Thorgeirsson,et al.  Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. , 2015, Journal of hepatology.

[4]  M. Hung,et al.  miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin , 2015, Oncotarget.

[5]  M. Bouchard,et al.  Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. , 2015, World journal of gastroenterology.

[6]  Hui-Xiong Xu,et al.  The Role of MicroRNAs in Hepatocellular Carcinoma , 2018, Journal of Cancer.

[7]  S. Arora,et al.  Modulation of MicroRNAs by Phytochemicals in Cancer: Underlying Mechanisms and Translational Significance , 2015, BioMed research international.

[8]  H. Yao,et al.  A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis. , 2015, Cancer cell.

[9]  Meng Li,et al.  Hepatitis B Virus X Protein Stabilizes Cyclin D1 and Increases Cyclin D1 Nuclear Accumulation through ERK-Mediated Inactivation of GSK-3β , 2015, Cancer Prevention Research.

[10]  J. Qian,et al.  MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer. , 2015, International journal of clinical and experimental medicine.

[11]  Ye Zhang,et al.  miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1 , 2015, Tumor Biology.

[12]  George A Calin,et al.  A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients , 2014, Clinical Cancer Research.

[13]  J. Cheong,et al.  Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression. , 2014, Cancer letters.

[14]  E. Azhar,et al.  Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. , 2014, World journal of gastroenterology.

[15]  Hao Zhou,et al.  Re-expression and epigenetic modification of maspin induced apoptosis in MCF-7 cells mediated by myocardin. , 2014, Cellular signalling.

[16]  W. N. Chen,et al.  MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects. , 2014, World journal of gastroenterology.

[17]  Yuepeng Sun,et al.  [HBx silencing by shRNA down-regulates MMP-2 expression in human hepatocellular carcinoma cell HepG2.2.15]. , 2014, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[18]  Huifang Liang,et al.  HBx Protein Promotes Oval Cell Proliferation by Up-Regulation of Cyclin D1 via Activation of the MEK/ERK and PI3K/Akt Pathways , 2014, International journal of molecular sciences.

[19]  Chia-Hung Chen,et al.  Trichostatin A Suppresses EGFR Expression through Induction of MicroRNA-7 in an HDAC-Independent Manner in Lapatinib-Treated Cells , 2014, BioMed research international.

[20]  Sheng-Chieh Hsu,et al.  BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib , 2013, PloS one.

[21]  Chia-Hung Chen,et al.  Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors , 2013, BMC Genomics.

[22]  P. S. Mitchell,et al.  Systematic Screen Identifies miRNAs That Target RAD51 and RAD51D to Enhance Chemosensitivity , 2013, Molecular Cancer Research.

[23]  J. Kuang,et al.  [Hepatitis B virus X promotes HepG2 cell cycle progression and growth via downregulation expression of p16 protein]. , 2013, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[24]  Xianxin Li,et al.  Identification of miR-7 as an oncogene in renal cell carcinoma , 2013, Journal of Molecular Histology.

[25]  Tzung-Chi Huang,et al.  Hepatitis B Virus-Encoded X Protein Downregulates EGFR Expression via Inducing MicroRNA-7 in Hepatocellular Carcinoma Cells , 2013, Evidence-based complementary and alternative medicine : eCAM.

[26]  M. Hung,et al.  Exogenous expression of human SGLT1 exhibits aggregations in sodium dodecyl sulfate polyacrylamide gel electrophoresis. , 2013, American journal of translational research.

[27]  Vijay Kumar,et al.  The HBx protein of hepatitis B virus confers resistance against nucleolar stress and anti‐cancer drug‐induced p53 expression , 2013, FEBS letters.

[28]  C. Tu,et al.  Lapatinib , 2013, Reactions Weekly.

[29]  L. Rybak,et al.  Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway , 2012, PloS one.

[30]  M. Hendrix,et al.  Maspin: molecular mechanisms and therapeutic implications , 2012, Cancer and Metastasis Reviews.

[31]  S. Nair,et al.  Emerging roles for modulation of microRNA signatures in cancer chemoprevention. , 2012, Current cancer drug targets.

[32]  M. Hung,et al.  Hepatitis B virus X protein induces IKKα nuclear translocation via Akt‐Dependent phosphorylation to promote the motility of hepatocarcinoma cells , 2012, Journal of cellular physiology.

[33]  Vijay Kumar,et al.  Akt augments the oncogenic potential of the HBx protein of hepatitis B virus by phosphorylation , 2012, The FEBS journal.

[34]  Hong Zhang,et al.  Effect of environmental factors on chemoresistance of HepG2 cells by regulating hypoxia-inducible factor-1α. , 2012, Chinese medical journal.

[35]  J. Ruland Return to homeostasis: downregulation of NF-κB responses , 2011, Nature Immunology.

[36]  I. Jacobson,et al.  Managing patients with hepatitis-B-related or hepatitis-C-related decompensated cirrhosis , 2011, Nature Reviews Gastroenterology &Hepatology.

[37]  M. Kew Hepatitis B virus x protein in the pathogenesis of hepatitis B virus‐induced hepatocellular carcinoma , 2011, Journal of gastroenterology and hepatology.

[38]  Yan He,et al.  Knockdown of HBx by RNAi inhibits proliferation and enhances chemotherapy-induced apoptosis in hepatocellular carcinoma cells , 2010, Medical oncology.

[39]  C. Chao,et al.  Hepatitis B virus X protein prevents apoptosis of hepatocellular carcinoma cells by upregulating SATB1 and HURP expression. , 2010, Biochemical pharmacology.

[40]  B. Bartosch Hepatitis B and C Viruses and Hepatocellular Carcinoma , 2010, Viruses.

[41]  Jian Shi,et al.  High expression levels of IKKα and IKKβ are necessary for the malignant properties of liver cancer , 2010, International journal of cancer.

[42]  J. Davie,et al.  H3 phosphorylation: dual role in mitosis and interphase. , 2009, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[43]  Shuhan Sun,et al.  Up‐regulated microRNA‐143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression , 2009, Hepatology.

[44]  K. Lee,et al.  Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[45]  M. Karin,et al.  NF-κB signaling, liver disease and hepatoprotective agents , 2008, Oncogene.

[46]  C. Loffredo,et al.  Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. , 2008, Mutation research.

[47]  A. Nakagawara,et al.  ATM-dependent nuclear accumulation of IKK-α plays an important role in the regulation of p73-mediated apoptosis in response to cisplatin , 2008, Oncogene.

[48]  P. Allavena,et al.  Pathways connecting inflammation and cancer. , 2008, Current opinion in genetics & development.

[49]  J. Sung,et al.  RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma. , 2007, Cancer letters.

[50]  M. Hung,et al.  Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB , 2007 .

[51]  David A. Cheresh,et al.  Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin , 2007, Nature.

[52]  F. Real,et al.  Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer , 2007, Proceedings of the National Academy of Sciences.

[53]  Claus Scheidereit,et al.  IκB kinase complexes: gateways to NF-κB activation and transcription , 2006, Oncogene.

[54]  Michael Karin,et al.  Regulation and Function of IKK and IKK-Related Kinases , 2006, Science's STKE.

[55]  D. Min,et al.  Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1 , 2005, Oncogene.

[56]  Hung-Jen Liu,et al.  Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3. , 2005, Journal of hepatology.

[57]  K. McGlynn,et al.  Epidemiology and natural history of hepatocellular carcinoma. , 2005, Best practice & research. Clinical gastroenterology.

[58]  Z. Weng,et al.  Identification of conserved structural features at sequentially degenerate locations in transcription factor binding sites. , 2005, Genome informatics. International Conference on Genome Informatics.

[59]  Tae-Wook Chung,et al.  Hepatitis B viral HBx induces matrix metalloproteinase‐9 gene expression through activation of ERKs and PI‐3K/AKT pathways: Involvement of invasive potential , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  Victor G Corces,et al.  Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. , 2004, Trends in genetics : TIG.

[61]  Wyeth W. Wasserman,et al.  JASPAR: an open-access database for eukaryotic transcription factor binding profiles , 2004, Nucleic Acids Res..

[62]  R. Gaynor,et al.  Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression , 2003, Nature.

[63]  C. Martínez-A,et al.  The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. , 2002, The Journal of clinical investigation.

[64]  F. Rösel,et al.  Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. , 2002, Biochemical and biophysical research communications.

[65]  S. Sheng,et al.  Maspin sensitizes breast carcinoma cells to induced apoptosis , 2002, Oncogene.

[66]  Hong Duan,et al.  Role for DNA methylation in the control of cell type–specific maspin expression , 2002, Nature Genetics.

[67]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[68]  O. Volpert,et al.  Maspin is an angiogenesis inhibitor , 2000, Nature Medicine.

[69]  Tatsuhiko Tsunoda,et al.  Estimating transcription factor bindability on DNA , 1999, Bioinform..

[70]  A. Graessmann,et al.  The Hepatitis B Virus HBx Protein Inhibits Caspase 3 Activity* , 1998, The Journal of Biological Chemistry.

[71]  M. Hendrix,et al.  Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.